Recent research shows younger heart disease patients face unique parenting challenges, middle-aged healthy eating protects against cognitive decline, and timing evening meals three hours before bed improves cardiovascular markers.
AstraZeneca's CALQUENCE received FDA approval as the first all-oral, fixed-duration regimen for chronic lymphocytic leukemia, while the EMA validated the marketing authorization application for ENHERTU in HER2-positive breast cancer treatment.
The FDA approved acalabrutinib plus venetoclax as the first all-oral, fixed-duration regimen for previously untreated chronic lymphocytic leukemia, based on phase III AMPLIFY trial results showing 35% reduction in disease progression or death risk versus chemoimmunotherapy.
The FDA has approved pitolisant tablets for treating cataplexy in pediatric patients aged 6 and older with narcolepsy, making it the only non-scheduled therapy approved for both pediatric and adult narcolepsy patients with or without cataplexy.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07564349 |
Comparison of 7-Day ECG Patches |
ACTIVE_NOT_RECRUITING | NA |
| NCT07402798 |
Anesthetic Safety of High-Frequency, Very-Low Tidal Volume Ventilation With Controlled Peak Pressure During Atrial Fibrillation Ablation |
COMPLETED | |
| NCT07020910 |
Bad Berka Heart Rhythm Registry of Patients With or at Risk of Arrhythmias Treated at Heart Center Bad Berka |
RECRUITING | |
| NCT06908369 |
Cardiac Symptoms in Patients With Treated Graves' Disease |
ACTIVE_NOT_RECRUITING | |
| NCT06898307 |
Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART |
RECRUITING | |
| NCT06854081 |
EluPro Antibiotic-Eluting BioEnvelope Registry |
RECRUITING | |
| NCT06772493 |
ViewFlex X ICE First-in-Human Study |
RECRUITING | |
| NCT05890716 |
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM) |
RECRUITING | |
| NCT05771142 |
Evaluation of an Innovative Smart T-shirt Capable to Monitor ECG Signal and Related Parameters Through the Comparison With a Holter ECG and a Smartwatch |
UNKNOWN | |
| NCT05724121 |
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax |
RECRUITING |
